Tech Company Financing Transactions
AltheRx Pharmaceuticals Funding Round
AltheRx Pharmaceuticals closed a $15 million funding round on 5/3/2013. Investors included Becker Ventures and BioStar Ventures.
Transaction Overview
Company Name
Announced On
5/3/2013
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Undisclosed
Investors
Becker Ventures (James Bennethum)
BioStar Ventures (Jeffrey O'Donnell)
Proceeds Purpose
With new leadership and new funding, AltheRx will continue to focus on advancing its lead candidate solabegron into Phase III trials.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Exton, PA 19341
USA
Exton, PA 19341
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
AltheRx Pharmaceuticals is a privately held, clinical development company focused on advancing best-in-class compounds.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jim Bennethum
Chief Scientific Officer
Eliot Ohlstein
VP - Operations
Raymond Stevens
Browse more venture capital transactions:
Prev: 5/3/2013: Poppin venture capital transaction
Next: 5/3/2013: Kloudless venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs